论文部分内容阅读
人类肿瘤疫苗治疗的目标是诱导肿瘤特异性和长期的免疫应答,以清除体内肿瘤。树突状细胞(dendriticcells,DC)是一类专职的抗原提呈细胞,在诱导、调节、维持机体抗肿瘤免疫中起核心作用[1]。本文就DC的肿瘤疫苗研究进展作一综述。树突状细胞概述1.DC生物学特性人DC发育经历4个阶
The goal of human tumor vaccine therapy is to induce tumor-specific and long-term immune responses to clear tumors in the body. Dendritic cells (DCs) are specialized antigen-presenting cells and play a central role in inducing, regulating and maintaining the body’s anti-tumor immunity [1]. This article reviews the research progress of DC tumor vaccine. Dendritic cell overview 1. DC biological characteristics of human DC development through 4 steps